Table 1 Clinicopathologic and genetic features of melanocytic tumors with NTRK3 fusion.

From: Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes

Case

Age (years), sex

Location

Clinical description

Thickness (mm)a

Diameter (mm)a

Diagnosis (category)

Clinical follow-up

Studies performed

Copy number aberrations

NTRK3 fusion partner gene

1b

2, F

Shin

7 × 6-mm pink nodule, possible Spitz nevus or juvenile xanthogranuloma or mastocytoma

>1.5

6.0

Spitz nevus

NA

aCGH, RNA-Seq

Gain of 12p (distal to ETV6) loss of distal 15q (distal to NTRK3)

ETV6

2b

10, M

Cheek

Pilomatricoma?

4.2

4.7

Spitz nevus

NA

aCGH, RNA-Seq

Small loss near NTRK3, no broad/arm-level losses or gains

MYH9

3

45, F

Nose

Basal cell carcinoma

>1.4

3.6

Spitz nevus

NA

aCGH

Gain of 15q between MYO5A and NTRK3

MYO5A

4

2, M

Cheek

Growing pink papule, Spitz nevus, juvenile xanthogranuloma, pyogenic granuloma, wart

>3.7

7.3

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH

Gains of 12p (proximal to ETV6), gain of 15q (proximal to NTRK3) loss of 15q (distal to NTRK3)

ETV6

5

5, F

Cheek

Atypical nevus, concern for malignancy

2.6

6.7

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH

Gain of 5q, loss of distal 13q, gain of 15q between MYO5A and NTRK3 with alternating copy number state in gained segment suggestive of chromothripsis

MYO5A

6b

6, F

Cheek

Spitz nevus, keratotic nevus, verruca vulgaris

2.6

2.5

Spitz melanocytoma (atypical Spitz tumor)

SLNB with deposit in 1/2 nodes. Completion lymphadenectomy with 0/33 nodes involved. No recurrence (6 years)

aCGH, RNA-Seq

Loss of 15q (distal to NTRK3), loss of portions of proximal 7q, loss of proximal 12q, loss of distal 18q

ETV6

7b

7, M

Cheek

Not available

1.5

4.4

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH, RNA-Seq

Loss of distal 15q (distal to NTRK3), small deletion on 12p involving 3′ end of ETV6 and deletion of proximal 12q, loss of most of 8p

ETV6

8

10, F

Dorsal wrist

Cyst, pilomatricoma?

5.5

5.7

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH

Gain of proximal 15q proximal to NTRK3 with high copy gain involving 5′ end of MYO5A and 3′ end of NTRK3, gain of distal 17q

MYO5A

9b

10, F

Earlobe

Nevus with central pyogenic granuloma

>1.2

2.9

Spitz melanocytoma (atypical Spitz tumor)

Complete excision, no recurrence (4.5 years)

aCGH, RNA-Seq

Small gain on 15q involving 5′ end of NTRK3, gain of distal 12p (distal to ETV6), gain of most of 2 (but not distal 2p)

ETV6

10b

16, F

Scalp

New nevus?

1.5

8.8

Spitz melanocytoma (atypical Spitz tumor)

Complete excision, no recurrence (3 years)

aCGH, RNA-Seq

Multiple losses on 15q with loss of 5′ end of NTRK3 and deep deletion of 3′ end of MYO5A alternating copy number states on 15 suggestive of chromothripsis

MYO5A

11

19, F

Ear

Not available

>3

4.0

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH

Gain of 12p (distal to ETV6), gain of 15q (proximal to NTRK3)

ETV6

12

21, M

Shoulder

Atypical nevus, basal cell carcinoma, amelanotic melanoma

0.7

2.8

Spitz melanocytoma (atypical Spitz tumor)

complete excision, no recurrence (7.5 years)

aCGH

Gain of 15q between MYO5A and NTRK3, loss of distal 4p, loss of portion of 10q (containing PTEN), loss of distal 11q

MYO5A

13

36, M

Shoulder

9 × 7-mm variegated deeply pigmented papule

0.7

7.3

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH

Gain of 15q between MYO5A and NTRK3

MYO5A

14

32, F

Lateral foot

8-mm papule

3.7

6.7

Spitz melanocytoma (atypical Spitz tumor)

NA

RNA-Seq

NA

MYO5A

15

38, M

Back

15-mm polypoid nodule

5.7

12.6

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH, RNA-Seq

Gain of 15q between MYO5A and NTRK3

MYO5A

16b

41, F

Trunk

Hemangioma, dysplastic nevus

≥1

6.7

Spitz melanocytoma (atypical Spitz tumor)

NA

aCGH, RNA-Seq

Focal deletions of 15q involving 3′ end of MYO5A, 5′ end of NTRK3

MYO5A

17

47, F

Back

6 × 3-mm brown exophytic lesion

1.1

3.7

Spitz melanocytoma (atypical Spitz tumor)

NA

RNA-Seq

NA

MYO5A

18b

72, F

Forehead

Nevus present for 30 years without change

0.9

7.6

Spitz melanocytoma (atypical Spitz tumor)

Complete excision, no recurrence (3 years)

aCGH, RNA-Seq

Loss of 15q proximal to MYO5A and distal to NTRK3

MYO5A

19

1, M

Cheek

3-mm papule, juvenile xanthogranuloma, or Spitz nevus

>1.6

4.5

Melanoma

NA

aCGH

Gain of 15q (proximal to NTRK3), loss of distal 15q with alternating copy number states suggestive of chromothripsis, gain of 12p (distal to ETV6). loss of 8p, loss of distal 20p, loss of proximal 21q

ETV6

20

29, M

Elbow

Cyst, subcutaneous nodule

>5

11.0

Melanoma

NA

aCGH

Gains and losses of 15q with gain of 5′ end of MYO5A and loss of 5′ end of NTRK3 and alternating copy number states suggestive of chromothripisis, gain of distal 2q, small loss and gain on 4p, loss of 8p, losses of 9p with deep deletion of CDKN2A

MYO5A

21

44, F

Shoulder

15 × 10-mm nodule

8.2

10.3

Melanoma

NA

aCGH, RNA-Seq

Gain of 15q (distal to MYO5A) with additional gain if the 3′ end of NTRK3, loss of distal 1p, 2q, 7p, and 9q

MYO5A

22

74, M

Forearm

Not available

4

7.5

Melanoma

NA

aCGH

Gain of 15q (proximal to NTRK3), gain of 22q (distal to MYH9)

MYH9

  1. aCGH array-based comparative genomic hybridization, RNA-Seq transcriptome sequencing.
  2. aMaximum value measured in histopathologic sections of the tumor.
  3. bCases included in our earlier report on NTRK3-rearranged Spitz tumors [14].